Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
Roque Díaz(Universidad de Navarra), Alfonso Calvo(Universidad de Navarra)
Cited by 86
Related Papers
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer
|British Journal of Cancer|2009|53